Jessica Skarzynski

“In the field of triple-negative breast cancer, we're beginning to see some remarkable advances, mostly centering around the three paradigms that have become so attractive for the treatment of cancer: immunotherapy, targeted biologics and antibody-drug conjugates,” Dr. Howard A. “Skip” Burris, III said in an interview.

The death of actor Chadwick Boseman from colorectal cancer has brought to light that many people with cancer fight their battles quietly, and how even oncologists need to be considerate of a patient’s struggles despite how they appear.

The recent death of Chadwick Boseman highlights the need for earlier screening in colorectal cancer, especially for young people.

This week on the “CURE Talks Cancer” podcast, we spoke with Larry Whipple — a lung cancer survivor who became his own best advocate — about how his insistence on the best care led to results he could only dream of, and how other patients with cancer can take an active role in their own care, too.

Dr. Lori A. Leslie discuses the potential of combination therapies with the emerging agent cirmtuzumab for patients with mantle cell lymphoma.

Dr. Nathan A. Pennell discusses the key genetic markers for treating patients with non-small cell lung cancer with targeted therapies.

In our final recipe in the Cooking with CURE series, our oncology dietitian friends at the John Theurer Cancer Center provide an interesting twist on the classic hummus recipe.

As the COVID-19 pandemic continues to impact the care of patients with metastatic renal cell carcinoma and other cancers, health care professionals are working together to stay vigilant and make the best treatment decisions for their patients by pooling their data with tools like the COVID-19 and Cancer Consortium, says Dr. Toni K. Choueiri.

Many factors impact outcomes in patients with advanced renal cell carcinoma, but recent findings suggest a patient’s age and gender are perhaps more important than previously realized.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for August 2020.

In addition to improving progression-free survival, researchers have found single-agent Ninlaro (ixazomib) to be a tolerable option in patients with newly diagnosed multiple myeloma who have also already undergone an autologous stem cell transplant.

This easy and healthy mango smoothie bowl recipe from the oncology dietitians at the John Theurer Cancer Center is sure to add some life to your breakfast when you get bored of your tried and true go-to’s.

In this week’s episode of the CURE® Talks Cancer podcast, surgical oncologist Dr. Margo Shoup sits down with CURE® to shed some light on retroperitoneal sarcoma and shares her thoughts on what patients need to know about its diagnosis and treatment.

At a median follow-up of 10 months, all patients who received Tafinlar plus Mekinist achieved an overall response rate of 51%.

Dr. Jennifer L. Atlas notes that while these results could lead to a paradigm shift, surgery and radiation aren’t being eliminated as treatment options.

Despite recent advances in the treatment of multiple myeloma, more must be done to find effective treatment options for patients with advanced disease, according to Dr. Luciano J. Costa.

This quick weeknight dinner option from the oncology dietitians at the John Theurer Cancer Center is high in protein and fiber, yet low in carbs, and is sure to be a crowd pleaser.

While the use of CAR-T cell therapy is currently still being investigated in patients with multiple myeloma, Dr. Nina Shah of the UCSF Helen Diller Family Comprehensive Cancer Center believes that these clinical trials will be what ultimately moves the field forward.

The future of multiple myeloma is heading toward combination therapies and CAR-T cell treatments, according to Dr. Betsy O'Donnell.

In patients with diffuse large B-cell lymphoma, low muscle mass (LMM) and low muscle density (LMD) could play a role when deciding what kind of treatment option to pursue, and could also impact a patient’s odds of survival, according to a recent study.

Prostate cancer treatments can cause side effects in a part of the body that might be unexpected— the heart. Here's how one expert believes patients can mitigate them. 

For newly diagnosed patients with ovarian cancer, a recent study shows how too much chemotherapy can lead to less favorable results.

After a cancer diagnosis, Maryland Governor Larry Hogan had to lean on family from both his personal and professional life to helping take on treatment and beat cancer twice.

Genetic testing is proving itself to be a vital tool in treating patients with prostate cancer but educating men on its importance also needs to take priority.

In this week’s episode of the CURE Talks Cancer podcast, oncology dietitian Rachel Wong shares some insight into the dietary modifications patients with cancer can make to ensure they maintain their nutrition and stay healthy through their treatment and beyond.

This healthy faux-ice cream recipe from the oncology dietitians at the John Theurer Cancer Center will be sure to provide our readers with some much-needed relief from the summer heat.

“Overall, the take-home point is that it's a small study so far and the follow-up time is still short, but it is pretty exciting preliminary data,” said Dr. Courtney DiNardo about the combination of Tibsovo plus Venclexta – with or without Vidaza – in IDH1-mutated acute myeloid leukemia.

Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for July 2020.

In this week’s episode of the CURE Talks Cancer podcast, Maryland Governor Larry Hogan opens up about what it was like to go through cancer not once but twice, and why he considers every day a gift.

Save the date! We invite you to join CURE® for our next monthly #CureConnect Tweet Chat on Thursday, July 30, at 1 p.m. EST, to discuss cancer survivorship and all it entails.